A Novel tool for noninvasive diagnosis and tracking of patients with inflammatory bowel disease

Inflammatory Bowel Diseases

Volumn 19, Issue 4, 2013, Pages 999-1003

  Arasaradnam, Ramesh P ^a,b   Ouaret, Nathalie ^a   Thomas, Matthew G ^a   Quraishi, Nabil ^b,c   Nwokolo, Chuka U ^b   Bardhan, Karna D ^a,c   Covington, James A ^a  

^a UNIVERSITY OF WARWICK   (United Kingdom)

^b UNIVERSITY HOSPITALS COVENTRY AND WARWICKSHIRE NHS TRUST   (United Kingdom)

^c ROTHERHAM GENERAL HOSPITAL   (United Kingdom)

Author keywords

Electronic nose; FAIMS; Fermentome; Gut permeability; Inflammatory bowel disease; Real time

Indexed keywords

AZATHIOPRINE; BIOLOGICAL PRODUCT; MESALAZINE; STEROID; VOLATILE ORGANIC COMPOUND;

ADULT; AGED; ARTICLE; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; CROHN DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISCRIMINANT ANALYSIS; DISCRIMINANT FUNCTION ANALYSIS; DISEASE ACTIVITY SCORE; DISEASE SEVERITY; ELECTRONIC NOSE; ENTERITIS; FEMALE; FERMENTATION; FIELD ASYMMETRIC ION MOBILITY SPECTROMETER; FISHER'S DISCRIMINANT ANALYSIS; GAS; HUMAN; ION MOBILITY SPECTROMETRY; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETER; MULTICENTER STUDY; NON INVASIVE PROCEDURE; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; REMISSION; SENSITIVITY AND SPECIFICITY; ULCERATIVE COLITIS; URINALYSIS; URINE; BIOTECHNOLOGY; DISEASE ACTIVITY; FISHER DISCRIMINANT ANALYSIS; HISTOPATHOLOGY;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; COHORT STUDIES; COLITIS, ULCERATIVE; CROHN DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MASS SPECTROMETRY; MIDDLE AGED; PROGNOSIS; RECURRENCE; REMISSION INDUCTION; VOLATILE ORGANIC COMPOUNDS;

EID: 84876382204     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/MIB.0b013e3182802b26     Document Type: Article

References (13)

1. Conte MP, Schippa S, Zamboni I, et al. Gut-associated bacterial microbiota in paediatric patients with inflammatory bowel disease. Gut. 2006; 55:1760-1767.
2. Arasaradnam RP, Pharaoh MW, Williams GJ, et al. Colonic fermentation- more than meets the nose. Med Hypotheses. 2009;73:753-756.
3. Arasaradnam R, Quraishi N, Kyrou I, et al. Insights into 'fermentonomics': evaluation of volatile organic compounds (VOCs) in human disease using an electronic 'e' nose. J Med Eng Technol. 2011;35:87-91..
4. Arasaradnam RP, Quraishi N, Kumar S, et al. The gut in health and disease: scenting the different by 'electronic nose.' Gastroenterology. 2010;138 (suppl 1):S524-S525.
5. Arasaradnam RP, Bardhan KD. Bioactive Foods and Extracts-Cancer Treatment and Prevention. New York, NY: Taylor Francis; 2010.
6. Gardner JW, Craven M, Dow C, et al. The prediction of bacteria type and culture growth phase by an electronic nose with a multi-layer perceptron network. Meas Sci Technol. 1998;9:120-127.
7. Arasaradnam RP, Ouaret N, Joseph M, et al. Radiotherapy induced gut damage: identifying 'at risk' patients using an electronic 'e' nose. Gut. 2011;60:A108-A109.
8. Arasaradnam RP, Ouaret N, Thomas MG, et al. Evaluation of gut bacterial populations using an electronic e-nose and field asymmetric ion mobility spectrometry: further insights into 'fermentonomics.' J Med Eng Technol. 2012;36:333-337.
9. Tannock GW. The search for disease associated compositional shifts in bowel bacterial communities of humans. Trends Microbiol. 2008;16:488-495.
10. Mareau P. Bacterial flora in inflammatory bowel disease. Dig Dis. 2009; 27:99-103.
11. Darfeuille-Michaud A, Boudeau J, Bulois P, et al. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology. 2004;127:412-421.
12. Marchesi JR, Holmes E, Khan F, et al. Rapid and non-invasive metabonomic characterisation of inflammatory bowel disease. J Proteome Res. 2007;6:546-551.
13. Tamboli CP, Neut C, Desreumaux P, et al. Dysbiosis in inflammatory bowel disease. Gut. 2004;53:1-4.